WFA
ABBV icon

WestHill Financial Advisors’s AbbVie ABBV Stock Holding History

WestHill Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Sell
2,151
-6
-0.3% -$1.29K 0.09% 48
2026
Q1 		$469K Buy
2,157
+34
+2% +$7.54K 0.09% 47
2025
Q4 		$485K Sell
2,123
-24
-1% -$5.47K 0.09% 48
2025
Q3 		$497K Sell
2,147
-79
-4% -$16.1K 0.1% 44
2025
Q2 		$413K Sell
2,226
-82
-4% -$15.2K 0.09% 47
2025
Q1 		$484K Sell
2,308
-634
-22% -$123K 0.11% 42
2024
Q4 		$523K Buy
2,942
+176
+6% +$32.4K 0.12% 40
2024
Q3 		$546K Sell
2,766
-1
-0% -$187 0.12% 40
2024
Q2 		$475K Hold
2,767
– – 0.12% 37
2024
Q1 		$504K Sell
2,767
-414
-13% -$71.3K 0.12% 38
2023
Q4 		$493K Sell
3,181
-118
-4% -$17.2K 0.13% 36
2023
Q3 		$492K Buy
3,299
+239
+8% +$35.1K 0.14% 32
2023
Q2 		$412K Sell
3,060
-74
-2% -$10.9K 0.12% 40
2023
Q1 		$499K Sell
3,134
-545
-15% -$83.3K 0.15% 33
2022
Q4 		$595K Buy
3,679
+506
+16% +$77.6K 0.19% 32
2022
Q3 		$426K Hold
3,173
– – 0.15% 36
2022
Q2 		$486K Hold
3,173
– – 0.16% 34
2022
Q1 		$514K Sell
3,173
-45
-1% -$6.54K 0.15% 35
2021
Q4 		$436K Hold
3,218
– – 0.12% 40
2021
Q3 		$347K Buy
+3,218
New +$368K 0.11% 40
2021
Q1 		$360K Sell
3,328
-6
-0.2% -$642 0.13% 35
2020
Q4 		$357K Buy
+3,334
New +$320K 0.14% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WestHill Financial Advisors's ABBV Position: Q2 2026 in Review

WestHill Financial Advisors reduced its AbbVie (ABBV) stake by 0.28% in Q2 2026, selling an estimated $1.29K and leaving 2,151 shares worth $541K. The position accounts for 0.09% of the portfolio, ranked #48.

WestHill Financial Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $595K in Q4 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WestHill Financial Advisors held 2,151 shares of AbbVie worth $541K as of Q2 2026.
  • WestHill Financial Advisors sold 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.09% of WestHill Financial Advisors's portfolio in Q2 2026, its #48 holding.
  • WestHill Financial Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • WestHill Financial Advisors's AbbVie position peaked at $595K in Q4 2022.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WestHill Financial Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.